Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 22

1.

Viscerotropic disease: case definition and guidelines for collection, analysis, and presentation of immunization safety data.

Gershman MD, Staples JE, Bentsi-Enchill AD, Breugelmans JG, Brito GS, Camacho LA, Cottin P, Domingo C, Durbin A, Gascon J, Guenaneche F, Hayes EB, Jelenik Z, Khromava A, Martins Rde M, Wilson MM, Massy N, Nasidi A, Niedrig M, Sherwat A, Tsai T, Vilella A, Wilson ME, Kohl KS; Brighton Collaboration Viscerotropic Disease Working Group.

Vaccine. 2012 Jul 13;30(33):5038-58. doi: 10.1016/j.vaccine.2012.04.067. Epub 2012 May 4. No abstract available.

PMID:
22561144
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Shiga toxin binding to glycolipids and glycans.

Gallegos KM, Conrady DG, Karve SS, Gunasekera TS, Herr AB, Weiss AA.

PLoS One. 2012;7(2):e30368. doi: 10.1371/journal.pone.0030368. Epub 2012 Feb 13.

PMID:
22348006
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Guillain-Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data.

Sejvar JJ, Kohl KS, Gidudu J, Amato A, Bakshi N, Baxter R, Burwen DR, Cornblath DR, Cleerbout J, Edwards KM, Heininger U, Hughes R, Khuri-Bulos N, Korinthenberg R, Law BJ, Munro U, Maltezou HC, Nell P, Oleske J, Sparks R, Velentgas P, Vermeer P, Wiznitzer M; Brighton Collaboration GBS Working Group.

Vaccine. 2011 Jan 10;29(3):599-612. doi: 10.1016/j.vaccine.2010.06.003. Epub 2010 Jun 18. Review. No abstract available.

PMID:
20600491
[PubMed - indexed for MEDLINE]
4.

Patient-selected goal attainment for pessary wearers: what is the clinical relevance?

Komesu YM, Rogers RG, Rode MA, Craig EC, Schrader RM, Gallegos KA, Villareal B.

Am J Obstet Gynecol. 2008 May;198(5):577.e1-5. doi: 10.1016/j.ajog.2007.12.033.

PMID:
18455538
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Pelvic floor symptom changes in pessary users.

Komesu YM, Rogers RG, Rode MA, Craig EC, Gallegos KA, Montoya AR, Swartz CD.

Am J Obstet Gynecol. 2007 Dec;197(6):620.e1-6.

PMID:
18060953
[PubMed - indexed for MEDLINE]
6.

Relapse and recovery: five to ten year follow-up study of chemically dependent physicians--the Georgia experience.

Gallegos KV, Lubin BH, Bowers C, Blevins JW, Talbott GD, Wilson PO.

Md Med J. 1992 Apr;41(4):315-9.

PMID:
1569840
[PubMed - indexed for MEDLINE]
7.

The model medical marriage.

Talbott GD, Angres D, Gallegos KV, Bettinardi-Angres K, Collins J.

J Med Assoc Ga. 1991 Apr;80(4):221-3. No abstract available.

PMID:
1861124
[PubMed - indexed for MEDLINE]
8.

Effects of cocaine and other drugs of abuse on immune function.

Donahoe RM, Falek A, Madden JJ, Nicholson JK, Bokos P, Gallegos K, Veit R.

Adv Exp Med Biol. 1991;288:143-50. Review. No abstract available.

PMID:
1950728
[PubMed - indexed for MEDLINE]
9.

The effect of physician impairment on the family.

Gallegos KV, Bettinardi-Angres K, Talbott GD.

Md Med J. 1990 Nov;39(11):1007-11. Review.

PMID:
2233144
[PubMed - indexed for MEDLINE]
10.

Combined Alcoholics Anonymous and professional care for addicted physicians.

Galanter M, Talbott D, Gallegos K, Rubenstone E.

Am J Psychiatry. 1990 Jan;147(1):64-8.

PMID:
2293790
[PubMed - indexed for MEDLINE]
11.

t-butyl-4-hydroxyanisole as an inhibitor of tumor cell respiration.

Fones E, Amigo H, Gallegos K, Guerrero A, Ferreira J.

Biochem Pharmacol. 1989 Oct 15;38(20):3443-51.

PMID:
2818635
[PubMed - indexed for MEDLINE]
12.

Returning to work after rehabilitation: aftercare, follow-up, and workplace reliability.

Gallegos KV, Keppler JP, Wilson PO.

Occup Med. 1989 Apr-Jun;4(2):357-71. Review. No abstract available.

PMID:
2543087
[PubMed - indexed for MEDLINE]
13.

The Pilot Impaired Physicians Epidemiologic Surveillance System.

Talbott GD, Gallegos KV.

QRB Qual Rev Bull. 1988 Apr;14(4):133-6. No abstract available.

PMID:
3132677
[PubMed - indexed for MEDLINE]
14.

Addiction in anesthesiologists: drug access and patterns of substance abuse.

Gallegos KV, Browne CH, Veit FW, Talbott GD.

QRB Qual Rev Bull. 1988 Apr;14(4):116-22.

PMID:
3132674
[PubMed - indexed for MEDLINE]
15.

Substance abuse among health professionals.

Gallegos KV, Veit FW, Wilson PO, Porter T, Talbott GD.

Md Med J. 1988 Mar;37(3):191-7. No abstract available.

PMID:
3357377
[PubMed - indexed for MEDLINE]
16.

The Medical Association of Georgia's Impaired Physicians Program. Review of the first 1000 physicians: analysis of specialty.

Talbott GD, Gallegos KV, Wilson PO, Porter TL.

JAMA. 1987 Jun 5;257(21):2927-30.

PMID:
3573291
[PubMed - indexed for MEDLINE]
17.

The Pilot Impaired Physicians Epidemiologic Surveillance System (PIPESS).

Gallegos KV.

Md Med J. 1987 Mar;36(3):264-6. No abstract available.

PMID:
3586904
[PubMed - indexed for MEDLINE]
18.

MAG's computerized staging of chemical dependence.

Gallegos KV, Norton MA, Talbott GD.

J Med Assoc Ga. 1985 May;74(5):306-10. No abstract available.

PMID:
4009074
[PubMed - indexed for MEDLINE]
19.

Brain functioning and addiction: what neuropsychologic studies reveal.

Robinson EL, Fitzgerald JS, Gallegos K.

J Med Assoc Ga. 1985 Feb;74(2):74-9. No abstract available.

PMID:
3973516
[PubMed - indexed for MEDLINE]
20.

Characterization of Georgia's Impaired Physicians Program treatment population: data and statistics.

Gallegos KV, Norton M.

J Med Assoc Ga. 1984 Nov;73(11):755-8. No abstract available.

PMID:
6512425
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk